Skip to content

Study on autonomic inhibition neural circuits in schizophrenia based on EEG frequency regulation

Study on autonomic inhibition neural circuits in schizophrenia based on EEG frequency regulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065995
Enrollment
Unknown
Registered
2022-11-21
Start date
2022-12-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia

Interventions

Prefrontal lobe treatment group:tACS treatment
Superior temporal gyrus treatment group:tACS treatment
sham:no

Sponsors

Hefei Fourth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for patients with schizophrenia: 1. Aged 18-55 years; 2. Meet the structured clinical diagnostic criteria of DSM-IV and meet the diagnostic criteria for schizophrenia or schizophrenoid disorder; 3. Clinically stable; 4. Discontinue anti-Parkinson's disease drugs 24-48 hours before the experiment; 5. Participants abstained from smoking for 1 h prior to data collection. Inclusion criteria for healthy controls: 1. Aged 18-55 years; 2. Normal visual acuity or corrected vision; 3. Normal hearing; 4. Right-handed; 5. No excessive caffeine, alcohol, nicotine intake.

Exclusion criteria

Exclusion criteria: Exclusion Criteria for patients with schizophrenia: 1. History of cognitive impairment, such as ADHD, mental retardation, cognitive impairment, etc.; 2. History of head trauma, electroconvulsive therapy, syncope and black masking, substance addiction (excluding nicotine addiction); 3. Participants who are currently participating in other experiments are unwilling or unable to complete the entire experiment. Exclusion Criteria for healthy controls: 1. History of cognitive impairment, such as ADHD, mental retardation, cognitive impairment, etc.; 2. Diagnosis of a history of neurological or psychiatric disorders such as obsessive-compulsive disorder, anxiety disorder, personality disorder, etc.; 3. History of mental trauma or head trauma, such as major blows in life, blackness, electroconvulsive therapy, syncope; 4. Have taken drugs or substances that affect the central nervous system, such as antipsychotics, alcohol addiction, tobacco addiction, in the past 2 weeks; 5. Participants who are currently participating in other experiments are unwilling or unable to complete the entire experiment.

Design outcomes

Primary

MeasureTime frame
electroencephalogram (EEG);MRI;

Secondary

MeasureTime frame
Positive and negative symptom scales;Concise Psychiatric Rating Scale;Consensus Awareness Scale;Frontal lobe function assessment table;

Countries

China

Contacts

Public ContactWan Li

Hefei Fourth People's Hospital

wanli@ahmu.edu.cn+86 551 6361-6273

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026